Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Alys Hall who wrote (1102)	1/19/1998 5:26:00 PM
From: Tim K	Respond to of 3702

Alys - The link worked, thanks. It would have been great to use the conference to announce the new CEO, and progrees on clinicals. And to see IDEC, Coulter and Genetech mentioned in the article and not TCLN is a shame. If they had done a presentation at the conference they probably would have been in the article. I exchanged eMails with a biotech analyst two months ago asking about TCLN. His response: Don't they have a golden bullet? XXXX (don't rememmber symbol) had a golden bullet and they tanked, why won't this one? The technology seems so good, why can't they FIND A PARTNER and give up a few percent profit so they don't keep going in the hole ($50,000,000?) or reducing our share value?